Renowned luminaries in Personalized Medicine
Groundbreaking companies with emerging technologies
More than 1000 peers from around the globe
50 sessions in 3 parallel tracks
STANFORD HEALTH CARE, UCSF, & ORACLE
Data-Driven Rx & Dx
The availability of large clinical data and other data types (e.g. toxicology, pharmacogenomics, omics, etc.) combined with the fast-paced evolution of innovative data mining tools allows us to gain new and unprecedented molecular and clinical insights. These data have the potential to impact the world of healthcare in many ways: enabling the identification of new therapeutic targets, finding new uses for existing drugs, allows the identification and characterization of new diagnostic tools, or brings us closer to the understanding of the molecular details of poorly characterized diseases. In this session, we will discuss applications and advancements that build upon large data as applied to both the therapeutics and clinical diagnostics.
Atul Butte, M.D., Ph.D., Director, Institute for Computational Health Sciences, UCSF
Atul Butte, MD, PhD is the new Director of the new Institute of Computational Health Sciences (ICHS) at the University of California, San Francisco, and a Professor of Pediatrics. Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children's Hospital Boston, then received his PhD from Harvard Medical School and MIT. Read Full Bio
Asim Siddiqui, Ph.D., CTO, Numedii, Inc.
Dr. Siddiqui brings an extensive background in bioinformatics and software engineering to his role of CTO at NuMedii. Recently, he served as Vice President of Product Development at Natera where he built Natera’s product management and program management functions. Read Full Bio
Matt Franklin, Senior Vice President, Global Marketing, Foundation Medicine
Matt is the senior vice president of global marketing for Foundation Medicine, Inc. in Cambridge, MA. Matt is responsible for Foundation Medicine’s commercial comprehensive genomic profiling product portfolio including solid tumor, hematologic malignancy and ctDNA solutions. Read Full Bio
Slava Akmaev, Ph.D., CTO, Berg Health
Slava Akmaev, Ph.D. is Senior Vice President and Chief Analytics Officer at Berg. Dr. Akmaev leads innovation in Big Data analytics applied to fundamental patient management problems in healthcare, drug development, and diagnostics. Read Full Bio